Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00903916 · ClinicalTrials.gov registry record
Effect of Antipsychotics on Appetite Regulation
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 45
- Enrollment target
NCT00903916 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 45 participants.
The verdict
NCT00903916 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate changes in appetite-regulating hormones, body composition (weight, body fat%), and hunger ratings in persons early in treatment with one of four atypical antipsychotic medications (olanzapine, risperidone, ziprasidone, aripiprazole).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00903916
The ClinicalTrials.gov registry entry for NCT00903916 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00903916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00903916 about?
NCT00903916 is a clinical study titled "Effect of Antipsychotics on Appetite Regulation". The purpose of this study is to evaluate changes in appetite-regulating hormones, body composition (weight, body fat%), and hunger ratings in persons early in treatment with one of four atypical antipsychotic medications (olanzapine, risperidone, ziprasidone, aripiprazole).
What is the current status of trial NCT00903916?
This trial is currently completed. The enrollment target is 45 participants. The study started on 2007-08. Estimated completion is 2012-03.
Who is sponsoring clinical trial NCT00903916?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.